These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16492298)

  • 21. Explantation of implantable defibrillator leads using open heart surgery or percutaneous techniques.
    Camboni D; Wollmann CG; Löher A; Gradaus R; Scheld HH; Schmid C
    Ann Thorac Surg; 2008 Jan; 85(1):50-5. PubMed ID: 18154777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
    Schulz N; Püschel K; Turk EE
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardioverter defibrillator in maintenance hemodialysis patients with ventricular tachyarrhythmias: a single-center experience.
    Ito I; Kono K; Shinbo G; Tadokoro K; Abe C; Takemura N; Iemura T; Matsuhashi N; Nakano N; Ota S; Ishimitsu T; Matsuoka H
    Hemodial Int; 2009 Jan; 13(1):48-54. PubMed ID: 19210278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
    Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
    Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for mortality in patients with cardiac device-related infection.
    Baman TS; Gupta SK; Valle JA; Yamada E
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):129-34. PubMed ID: 19808457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of complications of endovascular chronic lead extractions from pacemakers and defibrillators: a single-operator experience.
    Agarwal SK; Kamireddy S; Nemec J; Voigt A; Saba S
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):171-5. PubMed ID: 18775042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complications of replacing implantable devices in response to advisories: a single center experience.
    Moore JW; Barrington W; Bazaz R; Jain S; Nemec J; Ngwu O; Schwartzman D; Shalaby A; Saba S
    Int J Cardiol; 2009 May; 134(1):42-6. PubMed ID: 18372058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
    Lo R; Mitrache A; Quan W; Cohen TJ
    J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal insufficiency predicts the time to first appropriate defibrillator shock.
    Hreybe H; Ezzeddine R; Bedi M; Barrington W; Bazaz R; Ganz LI; Jain S; Ngwu O; London B; Saba S
    Am Heart J; 2006 Apr; 151(4):852-6. PubMed ID: 16569548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pacemaker and internal cardioverter defibrillator lead extraction: a safe and effective surgical approach.
    Kratz JM; Toole JM
    Ann Thorac Surg; 2010 Nov; 90(5):1411-7. PubMed ID: 20971231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
    J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices.
    Duray GZ; Schmitt J; Cicek-Hartvig S; Hohnloser SH; Israel CW
    Europace; 2009 Mar; 11(3):297-302. PubMed ID: 19054788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency.
    Tolpin DA; Collard CD; Lee VV; Elayda MA; Pan W
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):873-9. PubMed ID: 19660351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
    Peterson PN; Daugherty SL; Wang Y; Vidaillet HJ; Heidenreich PA; Curtis JP; Masoudi FA;
    Circulation; 2009 Mar; 119(8):1078-84. PubMed ID: 19221223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nontraditional surgical approaches for implantation of pacemaker and cardioverter defibrillator systems in patients with limited venous access.
    Jaroszewski DE; Altemose GT; Scott LR; Srivasthan K; Devaleria PA; Lackey J; Arabia FA
    Ann Thorac Surg; 2009 Jul; 88(1):112-6. PubMed ID: 19559206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.